Seeking Alpha

Symmetry Medical (SMA -15.6%) falls after updating its FY13 outlook. "Based on actual results...

Symmetry Medical (SMA -15.6%) falls after updating its FY13 outlook. "Based on actual results for May, projected results for June, and the revised forecast for the H2," the company now sees FY13 revenue in the range of $400-415M versus previous guidance of $420-440M. Adjusted EPS should come in between $0.40-0.50 versus consensus of $0.63. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs